Agile Therapeutics Inc
NASDAQ:AGRX
Earnings Announcements
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results
Published: 03/30/2022 20:21 GMT
Agile Therapeutics Inc (AGRX) - Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update.
Q4 Loss per Share $0.20.
Q4 Loss per Share $0.20.
Revenue is expected to be $1.84 Million
Adjusted EPS is expected to be -$4.61
Next Quarter Revenue Guidance is expected to be $2.2 Million
Next Quarter EPS Guidance is expected to be -$4.34
More details on our Analysts Page.
Adjusted EPS is expected to be -$4.61
Next Quarter Revenue Guidance is expected to be $2.2 Million
Next Quarter EPS Guidance is expected to be -$4.34
More details on our Analysts Page.